|
Volumn 30, Issue 5, 1998, Pages 1900-1903
|
Clinical impact of neoral in thoracic organ transplantation
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIGESTIVE SYSTEM FUNCTION DISORDER;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
DRUG SAFETY;
DRUG TOLERABILITY;
GOUT;
HEADACHE;
HEART LUNG TRANSPLANTATION;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
KIDNEY FUNCTION;
MAJOR CLINICAL STUDY;
MICROEMULSION;
MUSCLE CRAMP;
PARESTHESIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREMOR;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
CYCLOSPORINE;
HEART TRANSPLANTATION;
HEART-LUNG TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFUSIONS, INTRAVENOUS;
KIDNEY FUNCTION TESTS;
LUNG TRANSPLANTATION;
METABOLIC CLEARANCE RATE;
MIDDLE AGED;
TIME FACTORS;
|
EID: 0031657653
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00475-8 Document Type: Conference Paper |
Times cited : (5)
|
References (17)
|